ESTRO35 Programme Book

ELECTRONIC POSTERS

> Can mucosal criteria estimate response in rectal cancer treated with neoadjuvant chemoradiotherapy? A. Garant (Canada), T. Niazi, A. Gologan, A. Spatz, J. Faria, N. Morin, C. Vasilevsky, M. Boutros, T. Vuong > Association between obesity and local control of rectal cancer after surgery and radiotherapy Y.S. Choi (Republic of Korea) > Intensified neo-adjuvant chemoradiotherapy in locally advanced rectal cancer: long-term follow-up F. De Felice (Italy), D. Musio, A.L. Magnante, N. Bulzonetti, I. Benevento, R. Caiazzo, V. Tombolini > Total mesorectal excision vs. local excision following preoperative RT for “early” cT3 rectal cancer Y. Shin (Republic of Korea), J.H. Park, J.C. Kim, C.S. Yu, T.W. Kim, J.H. Kim > Anal cancer as a second human papillomavirus-related presentation after cervical dysplasia/neoplasia A. Yates (Australia), S. Pendlebury, E. Segelov > A correlation between PTV dosimetric criteria and pathological response in rectal cancer patients A. Franzetti Pellanda (Switzerland), P. Urso, S. Gianolini, B. De Bari, G. Ballerini, L. Negretti, C. Vite, N. Corradini > Impact of 18F-FDG-PET/CT in evaluating the response to neadjuvant chemoradiotherapy in rectal cancer S. Pedraza Fernández (Spain), M. Pérez-Escutia, D. Sánchez-Fuentes, P. Nenclares, S. Ruiz-Solís, M. Peña, D. Lora, J. Pérez-Regadera S. Montrone (Italy), C. Vivaldi, G. Coraggio, M. Cantarella, B. Manfredi, C. Laliscia, G. Masi, F. Loupakis, A. Falcone, M.G. Fabrini, A. Sainato, F. Pasqualetti > Tomotherapy for anal cancer: analysis of toxicity and response in a dual institution experience P. Bonomo (Italy), B. Meduri, E. D’Angelo, A. Galardi, C. Delli Paoli, C. Tata, G. De Marco, I. Desideri, F. Bertoni, L. Livi > Stereotactic radiotherapy in oligometastatic patients with lung metastasis from colon-rectal cancer

EP-1291

EP-1292

EP-1293

EP-1294

EP-1295

EP-1296

EP-1297

EP-1298

EP-1299

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

241